4960 logo

Braxia Scientific DB:4960 Stock Report

Last Price

€0.002

Market Cap

€936.5k

7D

0%

1Y

-66.7%

Updated

03 Nov, 2024

Data

Company Financials

4960 Stock Overview

Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. More details

4960 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Braxia Scientific Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Braxia Scientific
Historical stock prices
Current Share PriceCA$0.002
52 Week HighCA$0.013
52 Week LowCA$0.001
Beta1.25
1 Month Change0%
3 Month Change0%
1 Year Change-66.67%
3 Year Change-98.40%
5 Year Changen/a
Change since IPO-99.70%

Recent News & Updates

Recent updates

Shareholder Returns

4960DE HealthcareDE Market
7D0%-3.8%-2.0%
1Y-66.7%15.6%6.9%

Return vs Industry: 4960 underperformed the German Healthcare industry which returned 24.7% over the past year.

Return vs Market: 4960 underperformed the German Market which returned 13.2% over the past year.

Price Volatility

Is 4960's price volatile compared to industry and market?
4960 volatility
4960 Average Weekly Movementn/a
Healthcare Industry Average Movement4.7%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 4960's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 4960's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aRoger McIntyrebraxiascientific.com

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform.

Braxia Scientific Corp. Fundamentals Summary

How do Braxia Scientific's earnings and revenue compare to its market cap?
4960 fundamental statistics
Market cap€936.53k
Earnings (TTM)-€6.37m
Revenue (TTM)€1.46m

0.6x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4960 income statement (TTM)
RevenueCA$2.21m
Cost of RevenueCA$1.89m
Gross ProfitCA$324.11k
Other ExpensesCA$9.96m
Earnings-CA$9.64m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.034
Gross Margin14.67%
Net Profit Margin-436.37%
Debt/Equity Ratio-29.6%

How did 4960 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/03 09:57
End of Day Share Price 2024/08/06 00:00
Earnings2023/12/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Braxia Scientific Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution